Filing Flows › Crexendo (CXDO) › R&D spending
Crexendo (CXDO) R&D spending by quarter
Crexendo's R&D spending was $1.8M in Q3 2026 (third quarter 2026), -0.2% from Q2 2026. Over the last 7 quarters it ranged from $1.3M (Q4 2025) to $1.8M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.8M | -0.2% | +29% |
| Q2 2026 | $1.8M | +17% | +27% |
| Q1 2026 | $1.6M | +16% | +3% |
| Q4 2025 | $1.3M | -5% | — |
| Q3 2025 | $1.4M | -2% | — |
| Q2 2025 | $1.4M | -6% | — |
| Q1 2025 | $1.5M | — | — |
Q3 2026 at a glance
Crexendo, Q3 2026: revenue $25.2M (+44% year over year), operating margin 4.3%, net earnings $1.1M, operating cash flow $4.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Crexendo's R&D spending?
Crexendo's R&D spending was $1.8M in Q3 2026 (third quarter 2026), -0.2% from Q2 2026.
How has Crexendo's R&D spending changed?
Over the last 7 quarters it ranged from $1.3M (Q4 2025) to $1.8M (Q2 2026).